149 related articles for article (PubMed ID: 11789675)
1. In vivo applications of PEG liposomes: unexpected observations.
Laverman P; Boerman OC; Oyen WJG ; Corstens FHM ; Storm G
Crit Rev Ther Drug Carrier Syst; 2001; 18(6):551-66. PubMed ID: 11789675
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G
J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
[TBL] [Abstract][Full Text] [Related]
3. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.
Laverman P; Brouwers AH; Dams ET; Oyen WJ; Storm G; van Rooijen N; Corstens FH; Boerman OC
J Pharmacol Exp Ther; 2000 Jun; 293(3):996-1001. PubMed ID: 10869403
[TBL] [Abstract][Full Text] [Related]
5. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
Ishida T; Atobe K; Wang X; Kiwada H
J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
[TBL] [Abstract][Full Text] [Related]
6. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 354(1-2):56-62. PubMed ID: 18083313
[TBL] [Abstract][Full Text] [Related]
7. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC
J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
[TBL] [Abstract][Full Text] [Related]
8. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.
Ishida T; Ichihara M; Wang X; Yamamoto K; Kimura J; Majima E; Kiwada H
J Control Release; 2006 May; 112(1):15-25. PubMed ID: 16515818
[TBL] [Abstract][Full Text] [Related]
9. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
Wang X; Ishida T; Kiwada H
J Control Release; 2007 Jun; 119(2):236-44. PubMed ID: 17399838
[TBL] [Abstract][Full Text] [Related]
10. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
11. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.
Ishida T; Ichikawa T; Ichihara M; Sadzuka Y; Kiwada H
J Control Release; 2004 Mar; 95(3):403-12. PubMed ID: 15023452
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid.
Semple SC; Harasym TO; Clow KA; Ansell SM; Klimuk SK; Hope MJ
J Pharmacol Exp Ther; 2005 Mar; 312(3):1020-6. PubMed ID: 15525796
[TBL] [Abstract][Full Text] [Related]
13. Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study.
Underwood C; van Eps AW; Ross MW; Laverman P; van Bloois L; Storm G; Schaer TP
Equine Vet J; 2012 Mar; 44(2):196-202. PubMed ID: 21696436
[TBL] [Abstract][Full Text] [Related]
14. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.
Wang XY; Ishida T; Ichihara M; Kiwada H
J Control Release; 2005 May; 104(1):91-102. PubMed ID: 15866337
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration.
Romberg B; Oussoren C; Snel CJ; Carstens MG; Hennink WE; Storm G
Biochim Biophys Acta; 2007 Mar; 1768(3):737-43. PubMed ID: 17223070
[TBL] [Abstract][Full Text] [Related]
16. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
Ishida T; Ichihara M; Wang X; Kiwada H
J Control Release; 2006 Oct; 115(3):243-50. PubMed ID: 17011060
[TBL] [Abstract][Full Text] [Related]
17. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor.
Abu Lila AS; Doi Y; Nakamura K; Ishida T; Kiwada H
J Control Release; 2010 Mar; 142(2):167-73. PubMed ID: 19861140
[TBL] [Abstract][Full Text] [Related]
18. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
Hatakeyama H; Akita H; Maruyama K; Suhara T; Harashima H
Int J Pharm; 2004 Aug; 281(1-2):25-33. PubMed ID: 15288340
[TBL] [Abstract][Full Text] [Related]
19. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
Metselaar JM; Bruin P; de Boer LW; de Vringer T; Snel C; Oussoren C; Wauben MH; Crommelin DJ; Storm G; Hennink WE
Bioconjug Chem; 2003; 14(6):1156-64. PubMed ID: 14624629
[TBL] [Abstract][Full Text] [Related]
20. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
